DarioHealth Corp., a Delaware-based firm that has developed a smart device to monitor glucose levels in the blood, is seeking to expand its sales in the US and Europe and in new markets, raising $5.1 million in a private placement of shares.
The funding round was led by OurCrowd’s Qure Digital Health fund.
The company’s mobile monitor, developed in Israel, helps patients manage their diabetes on the go by providing them an all-in-one blood glucose meter. The plastic device, which looks a bit like a cigarette lighter, has a lancing device, a holder for 25 diabetes monitoring strips, and a fold-out, USB-like meter that connects to smartphones or tablets.
Read more on The Times of Israel here.